TX-MARY-KAY-INC.
15.12.2022 17:06:38 CET | Business Wire | Press release
As a global leader in women’s empowerment and innovative science, Mary Kay Inc. announces six recipients of the 2022 Young Women in STEAM grant program for making tremendous contributions to STEAM fields worldwide – science, technology, engineering, the arts, and mathematics.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221215005712/en/
Mary Kay Inc. provides grants to young women making great strides in STEAM-related fields around the world. (Graphic: Mary Kay Inc.)
In 2020, Mary Kay launched the Young Women in STEAM grant program and social campaign to help shift the perception of “the face of science,” and encourage young women to pursue STEAM paths. According to UNESCO, the United Nations Educational, Scientific and Cultural Organization, women remain a significant minority in scientific fields and are still under-represented in areas such as computing, digital information technology, engineering, mathematics, and physics.
“At Mary Kay, we celebrate young women who are embracing higher education and careers in STEAM areas as we continue to help narrow the gender gap and bias in scientific and related fields,” said Dr. Lucy Gildea, Chief Innovation Officer, Product and Science for Mary Kay Inc. “It’s no secret that women are underrepresented in STEAM industries, and we want to help change that by providing impactful grants to encourage young women to continue their pursuits in STEAM-related fields. Our 2022 Young Women in STEAM grant recipients are blazing trails around the world and helping to solve some of humanity’s most complex problems through science and innovation. We are proud to recognize their contributions and by supporting these remarkable young women, we continue Mary Kay’s steadfast mission of enriching women’s lives worldwide.”
The recipients of Mary Kay’s 2022 Young Women in STEAM grant program are highlighted on the company’s global social media channels and will receive $2,500 USD grants to assist with their current or future STEAM endeavors.
The 2022 Young Women in STEAM grant recipients:
- Angela Busheska, 20 (Macedonia) – The social entrepreneur and research-innovator was inspired to pursue STEAM after joining her 7th grade math Olympiad team where she fell in love with solving problems. As a developer of the EnRoute app, Busheska helps users live a more sustainable lifestyle by utilizing machine learning algorithms to help users abandon fast fashion. She encourages other young women to join STEAM fields and looks forward to seeing humanity utilize STEAM technologies for greater social good.
- Fengyun Chen, 17 (China) – Her projects entail physics and the role of clean energy in environmental sustainability. In 2017, Chen founded Yun Energy, an alliance of science and technology innovation that serves 20,000 people per year through courses in scientific enlightenment and physics. She conducted a 30-day investigation with her father that also led to the invention of the Water Distribution Device of Power Generated by Geothermal Energy and Air 3.0. She believes STEAM education allows students to explore practical ideas through hands-on experimentation that stimulates creativity and imagination.
- Farzana Alam Eshita, 23 (Australia) – As a civil engineer and honors student at the Monash University in Australia, Eshita’s final year project focuses on investigating the development of shear bands in triaxially loaded sand bands using x-ray computed tomography. Her current projects also include engineering major road projects in accordance with Australian standards and development of a landmark sports complex structure highlighting excellence in architectural and urban design. Eshita believes being a female in a STEAM field offers a variety of benefits including the opportunity to gain confidence, improve problem-solving abilities, and develop new educational and employment prospects.
- Aruna Sherma, 20 (Germany) – Her project is focused on developing an alternative contrasting agent for MRI scans that replace the conventional agent, gadolinium. As a physics student, Sherma has worked in four different labs to develop the contrast agent, and a series of tests at the University of Hamburg has shown it to be biocompatible with a stronger effect in MRI scans at a lower dosage than conventional contrast. Although STEAM subjects can be daunting to many, she believes diversity is important in all fields and feels women are just as capable as men of shaping the future in technology and research.
- Jingyuan Xu, 31 (Germany) – The energy conversion technologist and sustainable energy champion is a research fellow at the Karlsruhe Institute of Technology in Germany. Xu’s research focuses on sustainable energy technologies to provide economical solutions in cooling, heating, and power. She is passionate about applying her knowledge and expertise to minimize global-primary energy use and reduce CO2 emissions. In her view, women in STEAM boost team spirit, and the diversity that comes with inclusivity produces better science. She encourages young girls to pursue STEAM fields with enthusiasm and follow their hearts to benefit the world with breakthrough science.
- Eizelle Yee, 30 (Philippines) – An environmentalist, architect, and entrepreneur, Yee is a founding member of Pocket Garden, a public space design collective started by a group of volunteers who co-create and design shareable green spaces in the Philippines. She believes women have a keen eye for detail that helps marry art and science in an organized fashion. When it comes to STEAM initiatives, she feels collaborations between diverse cultures and traditions can bring inclusive and relatable creations in the fields of science, technology, engineering, the arts, and mathematics.
For more information on the Young Women in STEAM grant program, visit https://newsroom.marykay.com/.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221215005712/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
